Additionally, the antibody approach proved effective for other cell types, such as mouse splenocytes with anti-H-2Kd-biotin with anti-CD45-biotin, and human leukemia cells (KOPN-8) with anti-β2M-biotin (Supplementary Fig. S7). Here, B2M is linked to leukemia.